4//SEC Filing
Klassen Preston 4
Accession 0001209191-23-036350
CIK 0001505512other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:48 PM ET
Size
5.6 KB
Accession
0001209191-23-036350
Insider Transaction Report
Form 4
Klassen Preston
DirectorPresident & Head of R & D
Transactions
- Award
Stock Option (Right to Buy)
2023-06-12+350,000→ 350,000 totalExercise: $1.46Exp: 2033-06-11→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest one year following the date of grant and the remainder of the shares vest in 36 equal installments on a monthly basis thereafter, such that the option is fully vested three years following the date of grant, subject to the reporting person's continuous service.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001493056
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:48 PM ET
- Size
- 5.6 KB